In a strategic evolution of its comprehensive family health platform, Menlo Park-based Carrot Fertility announced on Thursday a major expansion of its AI-native metabolic health program, "Sprints," to encompass the complexities of menopause. This move signals a significant shift in the corporate health landscape, as providers move beyond treating menopause as a mere symptomatic transition, instead reframing it as a critical metabolic life stage that requires precise, data-driven intervention.
Main Facts: A New Frontier in Menopausal Care
Carrot, a global leader in fertility and family-building benefits, is extending the capabilities of its "Sprints" program—originally designed to assist members navigating fertility hurdles linked to metabolic disorders—to support women throughout the menopause transition.
The integration of Sprints into Carrot’s menopause offering is a direct response to the physiological volatility inherent in midlife. Menopause is frequently accompanied by profound shifts in insulin resistance, cholesterol profiles, and blood pressure regulation. By leveraging AI to process data from wearable devices, the platform provides members with real-time, personalized guidance on nutrition, physical activity, sleep hygiene, and stress management.
Beyond the digital interface, the program maintains a human-centric approach. Members retain 24/7 access to human health coaches, nutritionists, and physical therapists specialized in the specific physiological needs of menopausal women. Furthermore, the platform facilitates access to clinical interventions, including hormone replacement therapy (HRT) and GLP-1 medications, when deemed medically necessary and safe.
Chronology: From Fertility Roots to Midlife Support
The development of this program is the result of years of data gathering and clinical refinement within the fertility space.
- Pre-2025: Carrot establishes itself as a premier platform for employers and health systems, providing end-to-end support for family building, including egg freezing, IVF, and surrogacy.
- Early 2025: The company launches "Sprints," an AI-powered metabolic care program. Initially, its primary focus was on addressing fertility challenges stemming from obesity, blood sugar dysregulation, and sperm health, helping members optimize their physiological readiness for conception.
- Late 2025: Recognizing the overlap in metabolic markers between fertility struggles and the physiological decline associated with aging, Carrot’s leadership identifies the menopause transition as an underserved gap in their existing continuum of care.
- December 2024/January 2025 (Present): Carrot formally announces the integration of Sprints into its menopause support suite, marking the first time the company has applied its metabolic framework to the midlife population.
Supporting Data: The High Cost of Silence
The expansion comes at a time when the "menopause gap" in medical education and workplace support has reached a boiling point. The statistics underscore an urgent need for the intervention Carrot is proposing:
- The Knowledge Deficit: Research indicates that more than 80% of women report feeling under-informed about the physical and psychological realities of menopause.
- The Clinical Shortfall: Perhaps more alarming is the training deficit among practitioners; studies show that only 20% of OB-GYNs receive formal, structured training in menopause management during their residency programs.
- The Economic Toll: The lack of support is not merely a personal health issue—it is a macroeconomic problem. Estimates suggest that unmanaged menopause symptoms contribute to $1.8 billion in lost workdays annually in the United States alone.
These figures paint a picture of a workforce demographic that is largely ignored by traditional healthcare systems, despite representing some of the most experienced and valuable talent within the modern corporate structure.
Official Responses: Reframing the Midlife Narrative
Tammy Sun, founder and CEO of Carrot, has been vocal about the necessity of this pivot. During the announcement, she emphasized that menopause is not a static event but a dynamic metabolic period.
"This is a period of life where metabolic health and your metabolic markers can fluctuate very dramatically," Sun stated. "Insulin resistance really changes during this period of time, and that means that your nutrition and your exercise and movement needs and habits really need to evolve with it. Sprints is taking what we have done and learned through our preconception program and applying the same principles and the same framework to midlife."
Sun was careful to position the program as a balanced approach that avoids the "pill-only" culture. While Carrot is prepared to provide access to GLP-1s and hormone therapies, the company’s core philosophy remains rooted in lifestyle modification.
"Many women will want access to GLP-1s, and we will be happy to support them in that effort, assuming it is medically appropriate and safe," Sun noted. "But similar to how we think about fertility treatments and the drugs and the surgeries and the treatments that are associated with fertility care, drugs and surgery are not the only part of the story. We want women to really maximize their ability to maintain and increase their vitality through lifestyle habits and behavior change."
Implications: The Future of Corporate Wellness
The implications of Carrot’s announcement extend far beyond their specific product offering.
1. The Rise of "Metabolic Intelligence"
By applying AI to the menopause transition, Carrot is setting a new standard for what "comprehensive" benefits look like. Companies are no longer expected to simply offer insurance that covers doctors’ visits; they are now being pushed to provide digital tools that actively monitor and improve employee health markers. This shift toward "metabolic intelligence"—the ability to use data to predict and mitigate health declines before they become chronic conditions—is likely to become a benchmark for competitive benefits packages.
2. Retaining Senior Talent
The $1.8 billion economic impact mentioned by Sun highlights a critical retention issue. As women reach the peak of their careers, they are often hit with a "perfect storm" of symptoms that can affect cognitive function, mood, and physical energy. By providing robust support, companies that partner with platforms like Carrot are effectively investing in their leadership pipeline. Supporting employees through menopause is becoming an essential pillar of diversity, equity, and inclusion (DEI) initiatives.
3. Increased Competition in the Femtech Space
Carrot is not alone in recognizing this market opportunity. The "menopause economy" is booming, with startups like Midi Health and Gennev already carving out significant territory by offering telehealth-focused menopause clinics. Carrot’s advantage lies in its existing integration with health plans and large-scale enterprise employers. By layering metabolic care onto an existing fertility platform, Carrot offers a "cradle-to-grave" (or at least "puberty-to-post-menopause") health journey that few competitors can currently match.
4. A Shift in Healthcare Delivery
Finally, this move signals a broader trend in digital health: the convergence of previously siloed specialties. By treating fertility and menopause through the same "metabolic" lens, Carrot is breaking down the walls between reproductive endocrinology and general wellness. This encourages a more holistic view of the patient, where the same health coaches and data insights follow a member through different stages of their life, fostering deeper trust and better long-term outcomes.
Conclusion
Carrot’s decision to expand its AI metabolic program into the menopause sector is a calculated, evidence-based response to a clear gap in the healthcare market. By combining the power of wearables and AI-driven coaching with the clinical oversight of specialists and the medical availability of modern therapeutics, the company is attempting to destigmatize menopause and provide a viable, scalable solution for employers.
As the demographic of the workforce ages, the ability for companies to support their most experienced employees through this transition will be a critical determinant of long-term economic stability and talent retention. Whether the "Sprints" model succeeds in curbing the $1.8 billion in lost productivity remains to be seen, but it is undoubtedly a significant step toward a more data-informed, compassionate future for women’s health.
